Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. L 084
2. L-084
1. 161715-24-8
2. Orapenem
3. Tbpm-pi
4. Me1211
5. L-084
6. Ljc 11,084
7. 2,2-dimethylpropanoyloxymethyl (4r,5s,6s)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
8. Ljc-11084
9. Me-1211
10. 95ak1a52i8
11. Tebipenempivoxil
12. Tebipenem [inn]
13. (4r,5s,6s)-(pivaloyloxy)methyl 3-((1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
14. (1r,5s,6s)-6-[1(r)-hydroxyethyl]-1-methyl-2-[1-(2-thiazolin-2-yl)azetidin-3-ylsulfanyl]-1-carba-2-penem-3-carboxylic Acid Pivaloyloxymethyl Ester
15. Tebipenem Pivoxil (l-084)
16. Tebipenem Pivoxil [inn]
17. Tebipenem Pivoxil(l-084)
18. Unii-95ak1a52i8
19. Orapenem (tn)
20. 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 3-((1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (4r,5s,6s)-
21. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid, 3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (4r,5s,6s)-
22. Mls006011128
23. Schembl305541
24. Tebipenem Pivoxil [mi]
25. Tebipenem Pivoxil [usan:inn]
26. Tebipenem Pivoxil [jan]
27. Chembl2107486
28. Tebipenem Pivoxil [usan]
29. Gtpl10864
30. Dtxsid00167228
31. Chebi:135799
32. Tebipenem Pivoxil [who-dd]
33. Ex-a1256
34. Hy-b0396
35. Who 7924
36. Zinc4217736
37. Tebipenem Pivoxil (jan/usan/inn)
38. Ljc 11084
39. Mfcd17215369
40. S2159
41. Akos015899532
42. Ccg-269673
43. Ljc-11,084
44. Ncgc00346570-01
45. Ncgc00346570-04
46. (pivaloyloxy)methyl (4r,5s,6s)-3-((1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
47. [(4r,5s,6s)-3-{[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl}-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbonyloxy]methyl 2,2-dimethylpropanoate
48. Ac-22712
49. As-75334
50. L-084;me1211
51. Smr004702908
52. L 084
53. C73086
54. D09598
55. Ab01566835_01
56. A854567
57. Q1623593
58. ((2,2-dimethylpropanoyl)oxy)methyl (4r,5s,6s)-3-((1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl)sulfanyl)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
59. (4r,5r,6s)-3-((1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid (2,2-dimethyl-1-oxopropoxy) Methyl Ester
60. (4r,5s,6s)-(pivaloyloxy)methyl3-((1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
61. 2,2-dimethylpropanoyloxymethyl (4r,5s,6s)-3-[1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
| Molecular Weight | 497.6 g/mol |
|---|---|
| Molecular Formula | C22H31N3O6S2 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 10 |
| Exact Mass | 497.16542806 g/mol |
| Monoisotopic Mass | 497.16542806 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 908 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DH - Carbapenems
J01DH06 - Tebipenem pivoxil
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
Side Chain of Tebipenem pivoxil
CAS Number : 179337-57-6
End Use API : Tebipenem Pivoxil
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Tebipenem Pivoxil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tebipenem Pivoxil, including repackagers and relabelers. The FDA regulates Tebipenem Pivoxil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tebipenem Pivoxil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tebipenem Pivoxil supplier is an individual or a company that provides Tebipenem Pivoxil active pharmaceutical ingredient (API) or Tebipenem Pivoxil finished formulations upon request. The Tebipenem Pivoxil suppliers may include Tebipenem Pivoxil API manufacturers, exporters, distributors and traders.
Tebipenem Pivoxil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tebipenem Pivoxil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tebipenem Pivoxil GMP manufacturer or Tebipenem Pivoxil GMP API supplier for your needs.
A Tebipenem Pivoxil CoA (Certificate of Analysis) is a formal document that attests to Tebipenem Pivoxil's compliance with Tebipenem Pivoxil specifications and serves as a tool for batch-level quality control.
Tebipenem Pivoxil CoA mostly includes findings from lab analyses of a specific batch. For each Tebipenem Pivoxil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tebipenem Pivoxil may be tested according to a variety of international standards, such as European Pharmacopoeia (Tebipenem Pivoxil EP), Tebipenem Pivoxil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tebipenem Pivoxil USP).
LOOKING FOR A SUPPLIER?
